ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Growth Shares
3 ASX 200 shares named as buys
Blue Chip Shares
Leading broker names 3 blue chip ASX shares to buy
Record Highs
The ResMed (ASX: RMD) share price was up 20% in June. Here's why
Share Market News
2 ASX 200 shares that might be buys for growth
Share Fallers
Why Collins Foods, Genworth Mortgage Insurance, Kathmandu, & ResMed are sinking
Broker Notes
ResMed (ASX:RMD) share price tumbles on broker downgrade
Share Market News
ASX 200 down 0.9%: Big four banks drop, Metcash charges higher
Blue Chip Shares
2 top blue chip ASX 200 shares rated as buys
Share Gainers
Why Actinogen, Novonix, ResMed, & Zip shares are pushing higher
Share Market News
ASX 200 down 0.5%: Costa's acquisition, Afterpay & Zip charge higher
Broker Notes
Top brokers name 3 ASX shares to buy today
Healthcare Shares
3 top ASX shares in sector selling at 30% discount: expert
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
